Ercan Abay

566 total citations
16 papers, 437 citations indexed

About

Ercan Abay is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Ercan Abay has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 5 papers in Psychiatry and Mental health and 3 papers in Pharmacology. Recurrent topics in Ercan Abay's work include Treatment of Major Depression (3 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Ercan Abay is often cited by papers focused on Treatment of Major Depression (3 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Ercan Abay collaborates with scholars based in Türkiye, United Kingdom and Netherlands. Ercan Abay's co-authors include Cengiz Tuğlu, Erdal Vardar, Okan Çalıyurt, Yasemin Görgülü, Erol Yalnız, Cem Çopuroğlu, Mert Özcan, Şükrü Palanduz, Mevlut Türe and Fatma Savran Oğuz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychopharmacology and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Ercan Abay

13 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ercan Abay Türkiye 7 235 186 77 60 48 16 437
Cengiz Tuğlu Türkiye 8 269 1.1× 194 1.0× 154 2.0× 51 0.8× 53 1.1× 15 512
Debbie G. A. Janssen Netherlands 5 257 1.1× 213 1.1× 54 0.7× 74 1.2× 65 1.4× 7 390
Ewa Ogłodek Poland 13 214 0.9× 142 0.8× 70 0.9× 32 0.5× 59 1.2× 37 450
Jennifer L. Kruse United States 11 213 0.9× 119 0.6× 127 1.6× 64 1.1× 33 0.7× 21 423
Nicole Lichtblau Germany 6 359 1.5× 265 1.4× 91 1.2× 62 1.0× 78 1.6× 8 553
Trusharth Patel United States 5 357 1.5× 249 1.3× 127 1.6× 98 1.6× 69 1.4× 8 544
Luca Sforzini United Kingdom 9 303 1.3× 194 1.0× 61 0.8× 60 1.0× 55 1.1× 16 417
M Just Poland 11 168 0.7× 113 0.6× 76 1.0× 29 0.5× 45 0.9× 21 383
Patricia Huezo-Diaz Switzerland 12 157 0.7× 172 0.9× 47 0.6× 49 0.8× 35 0.7× 21 475
R. Berghmans Belgium 4 252 1.1× 210 1.1× 56 0.7× 35 0.6× 51 1.1× 5 418

Countries citing papers authored by Ercan Abay

Since Specialization
Citations

This map shows the geographic impact of Ercan Abay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ercan Abay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ercan Abay more than expected).

Fields of papers citing papers by Ercan Abay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ercan Abay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ercan Abay. The network helps show where Ercan Abay may publish in the future.

Co-authorship network of co-authors of Ercan Abay

This figure shows the co-authorship network connecting the top 25 collaborators of Ercan Abay. A scholar is included among the top collaborators of Ercan Abay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ercan Abay. Ercan Abay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vardar, Erdal, et al.. (2021). Ziprasidone versus risperidone: Comparison of clinical efficacy and cardiac, extrapyramidal, and metabolic side effects in patients with acute exacerbation of schizophrenia and schizoaffective disorders. SHILAP Revista de lepidopterología.
2.
Kıvrak, Yüksel, et al.. (2017). Prevalence and Clinical Features of Body Dismorphic Disorder on Psychiatric Inpatients: A Cross-sectional Study in Edirne/TURKEY. Kafkas Journal of Medical Sciences. 7(2). 124–129. 1 indexed citations
3.
Görgülü, Yasemin, et al.. (2016). Marital adjustment and family functioning in bipolar disorder type I in comparison with rheumatoid arthritis. Journal of Clinical Psychiatry. 19(4). 167–175. 1 indexed citations
4.
Sertöz, Özen Önen, Ömer Aydemır, Hayriye Elbi, et al.. (2013). The Impact of Physical and Psychological Comorbid Conditions on the Quality of Life of Patients with Acute Myocardial Infarction: A Multi-Center, Cross-Sectional Observational Study from Turkey. The International Journal of Psychiatry in Medicine. 45(2). 97–109. 11 indexed citations
5.
Abay, Ercan, et al.. (2010). Epidemiology of obsessive compulsive disorder at high school students in Edirne city center. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 230–237. 3 indexed citations
6.
Abay, Ercan, et al.. (2010). Edirne ili merkezindeki lise öğrencilerinde obsesif-kompulsif bozukluğun epidemiyolojisi. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 230–237. 3 indexed citations
7.
Çopuroğlu, Cem, et al.. (2010). Acute stress disorder and post-traumatic stress disorder following traumatic amputation.. PubMed. 76(1). 90–3. 28 indexed citations
8.
Abay, Ercan, et al.. (2008). Datura stramonium zehirlenmesine bağlı deliryum: Bir olgu. 9(1). 54–57. 3 indexed citations
9.
Çalıyurt, Okan, et al.. (2005). [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].. PubMed. 16(4). 245–51. 6 indexed citations
10.
Tuğlu, Cengiz, et al.. (2005). Delirium and Extrapyramidal Symptoms Due to a Lithium-Olanzapine Combination Therapy: A Case Report. Journal of Korean Medical Science. 20(4). 691–691. 10 indexed citations
11.
Abay, Ercan, et al.. (2004). Clastogenicity of selective serotonin-reuptake inhibitors. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 558(1-2). 137–144. 23 indexed citations
12.
Tuğlu, Cengiz, et al.. (2003). Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology. 170(4). 429–433. 323 indexed citations
13.
Sarıkaya, Ali, et al.. (1999). Evaluation of dysthymic disorder with technetium-99 m hexamethylpropylene amine oxime brain single-photon emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 26(3). 260–264. 5 indexed citations
14.
Abay, Ercan, et al.. (1997). Erişkinlerde dikkat eksikliği/hiperaktivite bozukluğunun öykü, tanı ve ruhsal durum bakımından gözden geçirilmesi. 5(1). 19–28. 2 indexed citations
15.
Abay, Ercan, et al.. (1988). The Use of Calcium Channel Blockers in Psychiatry. 2(3). 205. 17 indexed citations
16.
Abay, Ercan, et al.. (1988). The Disorders of Water Balance In Psychiatric Patients. 2(3). 217. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026